Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kawski Investor Relations is a boutique strategic communications firm that provides specialized investor relations and financial advisory services to the life sciences and healthcare sectors. The firm assists biotechnology, pharmaceutical, and medical device companies in developing clear investment narratives and managing relationships with institutional investors and analysts. Led by industry veteran Robert Kawski, the consultancy offers expertise in IPO positioning, secondary offerings, and ongoing corporate communications. Their services are designed to help emerging healthcare companies navigate the complexities of the capital markets and maximize shareholder value.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kawski Investor Relations.